Insecticide-treated eave ribbons for malaria vector control in low-income communities.
Eave ribbons
Indoor residual spraying
Malaria
Spatial repellents
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
23 Oct 2021
23 Oct 2021
Historique:
received:
16
07
2021
accepted:
06
10
2021
entrez:
24
10
2021
pubmed:
25
10
2021
medline:
30
11
2021
Statut:
epublish
Résumé
Supplementary tools are required to address the limitations of insecticide-treated nets (ITNs) and indoor residual spraying (IRS), which are currently the core vector control methods against malaria in Africa. The eave ribbons technology exploits the natural house-entry behaviours of major malaria vectors to deliver mosquitocidal or repellent actives around eave spaces through which the Anopheles mosquitoes usually enter human dwellings. They confer protection by preventing biting indoors and in the peri-domestic outdoor spaces, and also killing a significant proportion of the mosquitoes. Current versions of eave ribbons are made of low-cost hessian fabric infused with candidate insecticides and can be easily fitted onto multiple house types without any additional modifications. This article reviews the evidence for efficacy of the technology, and discusses its potential as affordable and versatile supplementary approach for targeted and efficient control of mosquito-borne diseases, particularly malaria. Given their simplicity and demonstrated potential in previous studies, future research should investigate ways to optimize scalability and effectiveness of the ribbons. It is also important to assess whether the ribbons may constitute a less-cumbersome, but more affordable substitute for other interventions, such as IRS, by judiciously using lower quantities of selected insecticides targeted around eave spaces to deliver equivalent or greater suppression of malaria transmission.
Identifiants
pubmed: 34688285
doi: 10.1186/s12936-021-03945-2
pii: 10.1186/s12936-021-03945-2
pmc: PMC8542300
doi:
Substances chimiques
Insecticides
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
415Subventions
Organisme : consortium for advanced research training in africa
ID : B 8606.R02
Organisme : nihr-wellcome trust partnership for global health research international training fellowship
ID : 216448/Z/19/Z
Organisme : bill and melinda gates foundation
ID : OPP1177156
Organisme : Howard Hughes Medical Institute
ID : OPP1099295
Pays : United States
Organisme : sida
ID : 54100113
Organisme : deltas africa initiative
ID : 107768/Z/15/Z
Informations de copyright
© 2021. The Author(s).
Références
Trials. 2008 Jun 06;9:33
pubmed: 18538004
PLoS Med. 2014 Apr 15;11(4):e1001630
pubmed: 24736370
Parasit Vectors. 2018 Oct 22;11(1):550
pubmed: 30348209
Front Physiol. 2012 Jun 12;3:199
pubmed: 22701435
Am J Trop Med Hyg. 2003 Feb;68(2):177-81
pubmed: 12641408
Malar J. 2019 Mar 20;18(1):87
pubmed: 30894185
Parasit Vectors. 2021 Jan 11;14(1):42
pubmed: 33430963
J Vector Ecol. 2007 Jun;32(1):69-74
pubmed: 17633427
PLoS One. 2015 Jan 30;10(1):e0117396
pubmed: 25635688
Malar J. 2012 Jul 02;11:221
pubmed: 22747655
Malar J. 2020 Nov 11;19(1):408
pubmed: 33176805
Malar J. 2020 Apr 23;19(1):164
pubmed: 32321534
Malar J. 2016 Apr 25;15:233
pubmed: 27108961
Lancet. 2021 Feb 27;397(10276):805-815
pubmed: 33640067
Malar J. 2006 Feb 01;5:8
pubmed: 16451729
PLoS One. 2016 Mar 01;11(3):e0149738
pubmed: 26930058
Soc Sci Med. 2004 Aug;59(3):501-23
pubmed: 15144761
Malar J. 2008 Jan 07;7:2
pubmed: 18179686
Syst Rev. 2021 Jan 18;10(1):30
pubmed: 33455581
Malar J. 2020 Jan 15;19(1):22
pubmed: 31941508
PLoS One. 2018 Jun 11;13(6):e0198970
pubmed: 29889888
Malar J. 2018 Aug 17;17(1):298
pubmed: 30119666
Malar J. 2016 Aug 11;15(1):404
pubmed: 27515306
Parasit Vectors. 2013 Dec 05;6:340
pubmed: 24304974
Med Vet Entomol. 1987 Apr;1(2):185-92
pubmed: 2979531
Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):181-5
pubmed: 1887465
Malar J. 2021 Aug 30;20(1):357
pubmed: 34461911
Parasit Vectors. 2021 Jan 20;14(1):64
pubmed: 33472661
Cochrane Database Syst Rev. 2019 May 23;5:CD012688
pubmed: 31120132
Nat Commun. 2018 Nov 26;9(1):4982
pubmed: 30478327
Malar J. 2020 Mar 10;19(1):109
pubmed: 32156280
Parasit Vectors. 2017 Apr 20;10(1):197
pubmed: 28427437
Malar J. 2020 Apr 10;19(1):150
pubmed: 32276585
PLoS One. 2014 Dec 08;9(12):e110433
pubmed: 25485850
Malar J. 2019 Dec 10;18(1):414
pubmed: 31823783
PLoS Biol. 2020 Jun 25;18(6):e3000633
pubmed: 32584814
Malar J. 2011 Mar 31;10:73
pubmed: 21453519
Wellcome Open Res. 2017 Oct 2;2:96
pubmed: 29417094
PLoS Negl Trop Dis. 2017 Apr 7;11(4):e0005455
pubmed: 28388682
Health Policy Plan. 1999 Dec;14(4):313-21
pubmed: 10787647
Parasit Vectors. 2013 Mar 07;6:57
pubmed: 23497471
PLoS One. 2013 May 20;8(5):e62769
pubmed: 23700411
Malar J. 2019 Sep 18;18(1):314
pubmed: 31533739
Malar J. 2012 May 14;11:164
pubmed: 22583679
PLoS Med. 2011 Jan 25;8(1):e1000401
pubmed: 21311587
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22042-22050
pubmed: 32843339
Malar J. 2013 Mar 04;12:85
pubmed: 23496881
Parasit Vectors. 2012 Mar 20;5:54
pubmed: 22433128
Malar J. 2014 Nov 21;13:446
pubmed: 25413142
Sci Rep. 2021 Sep 10;11(1):18055
pubmed: 34508114
Philos Trans R Soc Lond B Biol Sci. 2021 Feb 15;376(1818):20190803
pubmed: 33357060
Trials. 2018 Mar 22;19(1):190
pubmed: 29566732
Parasit Vectors. 2015 Jun 12;8:322
pubmed: 26063216
Malar J. 2020 Apr 8;19(1):148
pubmed: 32268907
Malar J. 2018 Oct 17;17(1):368
pubmed: 30333015
Malar J. 2015 Jun 09;14:209
pubmed: 26055986
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Emerg Infect Dis. 2017 May;23(5):782-789
pubmed: 28418299
Malar J. 2011 Dec 13;10:353
pubmed: 22166144
Malar J. 2008 Dec 11;7 Suppl 1:S4
pubmed: 19091038
Malar J. 2009 Sep 29;8:221
pubmed: 19785779
Malar J. 2016 Sep 01;15(1):447
pubmed: 27586055
Lancet. 2018 Apr 21;391(10130):1577-1588
pubmed: 29655496
Malar J. 2017 Jul 4;16(1):274
pubmed: 28676051
Malar J. 2020 Jan 17;19(1):30
pubmed: 31952538
Malar J. 2015 Apr 23;14:173
pubmed: 25899397